← Back to headlines
GSK Inks $1 Billion Licensing Deal with China’s Frontier Bio
GSK has signed a licensing agreement with China's Frontier Bio, potentially worth up to $1 billion, for a new pharmaceutical development.
24 Feb, 13:51 — 24 Feb, 13:51
ℹOnly 1 source covers this story
